# China NMPA Drug Inspection - Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd. - dodder

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anhui-yishengyuan-traditional-chinese-medicine-pieces-technology-co-ltd/4212bada-9017-461a-ae50-ea2b1a700733/
Source feed: China

> China NMPA drug inspection for Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd. published December 07, 2017. Drug: dodder. On December 7, 2017, the Heilongjiang Provincial Food and Drug Administration issued an announcement concerning nine bat

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from the Heilongjiang Provincial Food and Drug Administration regarding 9 batches of substandard traditional Chinese medicine decoction pieces (No. 10, 2017)
- Company Name: Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd.
- Publication Date: 2017-12-07
- Drug Name: dodder
- Inspection Finding: The non-compliant items were properties and inspection items.
- Action Taken: Relevant food and drug administration departments have taken control measures such as sealing and seizing, requiring the sampled units to suspend the sale and use of this batch of products and to rectify the situation. The provincial bureau has instructed the municipal (prefecture-level) food and drug administration departments where the sampled units are located to investigate the illegal sale of substandard drugs in accordance with Articles 73, 74, and 75 of the "Drug Administration Law of the People's Republic of China," and to publicly disclose the results of the handling of the relevant enterprises or units selling substandard drugs within three months.
- Summary: On December 7, 2017, the Heilongjiang Provincial Food and Drug Administration issued an announcement concerning nine batches of unqualified traditional Chinese medicine pieces. Tests conducted by five drug testing institutions, including the Heilongjiang Provincial Food and Drug Inspection and Testing Institute, identified non-compliance in products from five companies. These companies include Anhui Yishengtang Traditional Chinese Medicine Pieces Co., Ltd., Anhui Huadingtang Traditional Chinese Medicine Pieces Technology Co., Ltd., Hebei Jixintang Pharmaceutical Co., Ltd., Qiqihar Xianhe Traditional Chinese Medicine Pieces Processing Plant, and Harbin Runhe Traditional Chinese Medicine Pieces Processing Plant. The primary issues involved non-compliant items related to the appearance and other inspection criteria of the traditional Chinese medicine pieces. In response to these findings, regulatory authorities implemented immediate control measures, such as sealing and seizing the affected products. The sampled companies were mandated to cease sales and usage of the non-compliant batches and to implement corrective actions. Furthermore, municipal and prefecture-level food and drug administration departments were instructed to investigate the illegal sale of these substandard drugs. These departments are required to disclose the outcomes of their investigations concerning the involved enterprises within three months, in accordance with Articles 73, 74, and 75 of the *Drug Administration Law of the People's Republic of China*, and report their findings to the Provincial Bureau.

Company: https://www.globalkeysolutions.net/companies/anhui-yishengyuan-traditional-chinese-medicine-pieces-technology-co-ltd/c2292c5b-5423-41d2-824e-557e75208bc9/